期刊文献+

80株大肠埃希菌耐药性及氨基糖苷类修饰酶基因分析 被引量:8

Analysis on the resistance and genotyping of aminoglycoside modifying enzymes in Escherichia coli
下载PDF
导出
摘要 目的:了解临床分离的80株大肠埃希菌耐药性及氨基糖苷类修饰酶(AMEs)基因的存在状况。方法:采用MH平板法测试14种抗菌药物的敏感性,采用PCR技术检测氨基糖苷类修饰酶基因。结果:80株大肠埃希菌呈现多重耐药,对氨基糖苷类抗生素的耐药率在57.5%-80%之间,氨基糖苷类修饰酶基因aac(3)-I、aac(3)-Ⅱ、aac(6’)-I、ant(3”)-I基因的阳性率分别为20%、30%、32.5%、20%。携带1种或1种以上基因的菌株有65株(81.25%)。结论:临床分离的大肠埃希菌多重耐药严重,氨基糖苷类修饰酶基因携带率较高。 Objective: To investigate the resistance and genotyping of aminoglycoside modifying enzymes (AMEs) in Escherichia coli isolated from the clinic. Methods: M-H Tests were performed to detect the susceptibility of 14 kinds of antimicrobial agents against 80 strains of Escherichia coli. Genotypes of AMEs was analyzed by polymerase chain reaction(PCR). Results: Eighty strains were multiple-drug-resistance. The resistant rates to aminoglycosides ranged from 57.5% to 80% ,AMEs gene was found in 42.5%. The positive rates of AMEs genes of aac(3)- I ,aac(3)- Ⅱ ,aac(6')- I ,ant(3")- I were 20%, 30% ,32.5% and 20%, one of genes or some of genes were 65 strains (81.25%'). Conclusion: The muhidrug resistance Escherichia coli isolated from the clinic was a serious issue, and there were higher positive percentages genotyping of aminoglycoside modifying enzymes (AMEs) in Escherichia coli.
出处 《江苏大学学报(医学版)》 CAS 2006年第3期246-247,250,共3页 Journal of Jiangsu University:Medicine Edition
关键词 大肠埃希菌 氨基糖苷类修饰酶 基因 Escherichia coli aminolycoside modifying enzymes gene
  • 相关文献

参考文献4

二级参考文献19

  • 1陈代杰.抗菌生物与细菌耐药性[M].上海:华东理工大学出版社,2001.90-111.
  • 2Bergogne-Berezin E. Guideline on antimicrobial chemotherapy for prevention and treatment of infections in the ICU. J Chemother, 2001,1: 134-149.
  • 3Goossens H. MYSTIC program: summary of European data from 1997 to 2000. Diagn Microbiol Infect Dis, 2001, 41: 183-189.
  • 4Leblebicioglu H, Gunaydin M, Esen S, et al. Surveillance of antimicrobial resistance in gram-negative isolates from ICU in Turkey:analysis of data from the last 5 years. J Chemother, 2002, 14:140-146.
  • 5Karlowsky JA, Kelly LJ, Thornsberry C , et al. Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000:TRUST and TSN data for the United States. J Autimicrob Agents , 2002,19: 21-31.
  • 6National Committee for Clinical Laboratory Standards. 2002. Performance standards for antimicrobial susceptibility testing. Approved standard M100-S12. National Committee for Clinical Laboratory Standards,Wayne, Pa.2002,1.
  • 7Chanawong A. M' Zali FH, Heritage J, et al. Three cefotaximases,CTX-M-9, CTX-M-13, CTX-M-14, among Enterobacteriaceae in the People's Republic of China. Antimicrob Agents Chemother, 2002, 46:630-637.
  • 8NationalCommitteeforClinicalLabortoryStandards.Per formancestandarsforantimicrobialasusceptibilitytesting. NCCLSdocumentM100S 9 .
  • 9许锦民,苏丹虹.大肠埃希菌和克雷伯菌属产超广谱β-内酰胺酶的检测[J].中华医学检验杂志,1998,21(6):373-373. 被引量:64
  • 10张永龙,李家泰.北京地区临床分离菌对氨基糖苷类抗生素耐药情况调查研究及其耐药机理分析[J].中国抗生素杂志,1998,23(5):371-37. 被引量:12

共引文献657

同被引文献73

引证文献8

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部